Male Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report Forecast Period 2024-2031.
Male Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report Forecast Period 2024-2031.
Blog Article
The global male infertility diagnosis and treatment market is anticipated to grow at a significant CAGR of 4% during the forecast period. Infertility in men occurs due to a deficiency in sperm formation. Infertility can have several causes and may rely on genetics, fitness, diseases, general health, and dietary contaminants. Some crucial causes of male infertility may include abnormal production or functioning of sperms owing to diabetes, HIV, gonorrhea, among others, and damage associated with cancer and its treatment. Additionally, problems with sperm delivery owing to certain genetic diseases, such as cystic fibrosis, damage or injury to the reproductive system, and blockage in the testicle are also the major causes of male infertility.
Get Sample Copy of this Report at
https://www.omrglobal.com/request-sample/male-infertility-diagnosis-and-treatment-market
The major factors contributing to the growth of the global male infertility diagnosis and treatment market include a significant rise in the prevalence of infertility and considerable advances in the area of infertility. A significant rise in male infertility has been witnessed over the years. This may occur due to unhealthy lifestyle risk factors, such as psychological stress, alcohol, and caffeine consumption, cigarette smoking and obesity, and medical history. As per the US Department of Health and Human Services (HHS), out of 100 couples in the US, 12 to 13 have trouble conceiving. Nearly one-third of infertility cases resulted due to fertility problems in men and another one-third of fertility problems are due to fertility problems in women.
Impact of COVID-19 Pandemic on Global Male Infertility Diagnosis and Treatment Market
COVID-19 has driven up healthcare expenditures, altered healthcare supply networks, and lowered non-covid footfall and test numbers dramatically. Due to the pandemic's quick onset uncertainty plagued the business, worsening the ongoing economic crisis. Footfall and test volumes dropped by 70-80% as a result of the viral outbreak. Fear of contracting the virus from healthcare workers or other patients has led to a dramatic decline in in-person visits over the last two years. The pandemic reaction takes precedence over the needs of 'non-Covid' patients. For those with infectious diseases and chronic illnesses, even basic check-ups become stressful and costly.
Segmental Outlook
The global male infertility diagnosis and treatment market is segmented based on diagnostic tests and treatment. Based on diagnostic tests, the market is classified into semen analysis, urinalysis, genetic testing, testicular biopsy, hormonal tests, and others. Based on treatment, the market is segmented into drugs, ART therapy, and surgery.
By Diagnostic Tests (Semen Analysis, Urinalysis, Genetic Testing, Testicular Biopsy, Hormonal Tests, and Others)
By Treatment (Drugs, ART Therapy, and Surgery)
Market Players Outlook
The major companies serving the global male infertility diagnosis and treatment market include Merck KGaA, Halotech DNA SL, PerkinElmer, Inc., Vitrolife AB, and Medical Electronic Systems. among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2019, Merck Foundation launched the song “Life is Bigger” to raise awareness about male infertility in Africa and the Rest of the World. It is a part of a community awareness program which is referred to as Merck More than a Mother. This rising awareness initiative is supporting to create awareness among people, thereby increasing demand for male infertility diagnostic tests and treatment options.
The Report Covers
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Male Infertility Diagnosis and Treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
Inquire for Discount on this Report at
https://www.omrglobal.com/report-customization/male-infertility-diagnosis-and-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404 Report this page